2020 MOC articles
Predictive factors for lymph node metastases in vulvar cancer. An analysis of the AGO-CaRE-1 multicenter study
Lymph node (LN) metastasis is the most important prognostic factor in primary vulvar cancer. Assessing risk factors for the incidence and extent of LN metastases may help to select the optimal treatment strategy for each individual patient.Margin status revisited in vulvar squamous cell carcinoma
To determine the incidence of local recurrence of vulvar squamous cell carcinoma in relation to tumor- and/or precursor lesion free pathologic margins.Risk factors for anastomotic leakage after colorectal resection in ovarian cancer surgery: A multi-centre study
To determine pre-/intraoperative risk factors for anastomotic leak after modified posterior pelvic exenteration (MPE) or colorectal resection in ovarian cancer and to create a practical instrument for predicting anastomotic leak risk.How we use hospice: Hospice enrollment patterns and costs in elderly ovarian cancer patients
To describe disparities in patterns of hospice use and end-of-life costs among ovarian cancer patients.Utilizing the Patient Reported Outcomes Measurement Information System (PROMIS®) to increase referral to ancillary support services for severely symptomatic patients with gynecologic cancer
The Patient-Reported Outcomes Measurement Information System (PROMIS®) Network has developed a comprehensive repository of electronic patient reported outcomes measures (ePROs) of major symptom domains that have been validated in cancer patients. Their use for patients with gynecologic cancer has been understudied. Our objective was to establish feasibility and acceptability of PROMIS ePRO integration in a gynecologic oncology outpatient clinic and assess if it can help identify severely symptomatic patients and increase referral to supportive services.Opioid use in gynecologic oncology in the age of the opioid epidemic: Part I - Effective opioid use across clinical settings, a society of gynecologic oncology evidence-based review
Opioids are first-line treatment for cancer-related pain [1,2]. The legal and illicit use of opioids has recently entered the national conversation due to the sustained and dramatic increase in opioid-related deaths over the past decade. From 1999 to 2014, more than 165,000 deaths in the United States were attributed to opioid-related overdoses [3]. The broad term opioid misuse refers to any use of opioids for a purpose not consistent with legal or medical guidelines and includes recreational opioid use and diversion or sale of prescribed opioids for recreational use [4].
